Achieve Life Sciences Inc

ACHV11 Dec 2024
Healthcare
$4.54
-0.04 (-3.95%)
Lowest Today
$4.29
Highest Today
$4.66
Today’s Open
$4.54
Prev. Close
$4.56
52 Week High
$5.59
52 Week Low
$3.1
To Invest in Achieve Life Sciences Inc

Achieve Life Sciences Inc

Healthcare
ACHV11 Dec 2024
-0.04 (-3.95%)
1M
3M
6M
1Y
5Y
Low
$4.29
Day’s Range
High
$4.66
4.29
52 Week Low
$3.1
52-Week Range
52 Week High
$5.59
3.1
1 Day
-
1 Week
-3.3%
1 month return
-1.56%
3 month return
+2.33%
6 month return
-16.69%
1 Year return
+39.36%
3 Years return
-36.83%
5 Years return
-74.17%
10 Years return
-
Institutional Holdings
Franklin Resources Inc
11.26
Propel Bio Management LLC
7.13
Franklin Biotechnology Discovery A
6.34
BlackRock Inc
5.69
Vanguard Group Inc
5.64
Franklin Biotechnology Discv A(acc)USD
4.91
Sofinnova Ventures
4.4

Market Status

Fundamentals
Market Cap
156.82 mln
PB Ratio
4.95
PE Ratio
0
Enterprise Value
122.38 mln
Total Assets
19.37 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Organisation
Achieve Life Sciences Inc
Employees
22
Industry
Biotechnology
CEO
Dr. Richard A. B. Stewart
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities